Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044656
Filing Date
2024-11-12
Accepted
2024-11-12 13:05:36
Documents
44
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 937485
2 form10-q_001.jpg GRAPHIC 5204
3 ex31-1.htm EX-31.1 17259
4 ex31-2.htm EX-31.2 17580
5 ex32-1.htm EX-32.1 8446
  Complete submission text file 0001493152-24-044656.txt   3230906

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cqens-20240930.xsd EX-101.SCH 20873
7 XBRL CALCULATION FILE cqens-20240930_cal.xml EX-101.CAL 36988
8 XBRL DEFINITION FILE cqens-20240930_def.xml EX-101.DEF 72037
9 XBRL LABEL FILE cqens-20240930_lab.xml EX-101.LAB 204150
10 XBRL PRESENTATION FILE cqens-20240930_pre.xml EX-101.PRE 152358
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 325268
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 241446365
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)